Paloma Poza-Guedes

Learn More
physicians and pharmaceutical companies that PML could occur. Th is brings us to the topic of the biological plausibility of the rare event of PML in association with anti-adhesion therapies. We off er as a cautionary example the unexpected immunologic eff ect of serum antibodies to Abciximab. Th is monoclonal antibody therapy was designed to bind to the(More)
BACKGROUND Angiogenesis has a key role in several conditions and is regulated by several factors such as the platelet-derived growth factor (PDGF) or the vascular endothelial growth factor (VEGF). The goal of this study was to investigate the possible role of PDGF and VEGF in a group of patients with severe food allergy. METHODS We design a prospective(More)
BACKGROUND The nasal provocation test (NPT) with lysine aspirin is a useful tool in the diagnosis of aspirin-exacerbated respiratory disease (AERD), previously reffered to as Samter's disease. The aim of the present study focuses on methodological interventions to show the usefulness of the NPT with lysine aspirin in differentiating AERD patients from(More)
Critical Care [1]. In the issue of pharmacodynamics of βlactams we missed a particular subject: allergy, subtle but sometimes important in intensive and critical care units since clinicians usually manage patients labelled as ‘allergic’ without having been studied and based only on clinical history [2]. Th is creates a health resource problem and leads to(More)
Methods We selected 3 adult patients with a confirmed diagnosis of severe persistent allergic asthma (ATS criteria for severe asthma) for at least five years. Mean average topical steroid (inhaled) daily dose was above 1000 mcg of fluticasone propionate or 1600 mcg of budesonide. All patients included in the current trial were clinically relevant sensitized(More)
s from the Food Allergy and Anaphylaxis Meeting 2016 Rome, Italy. 13–15 October 2016 © The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give(More)